Sanofi and CD&R sign Opella share purchase agreement Paris, February 19, 2025. Following completion of the required social and corporate procedures, Sanofi and CD&R announce today they have signed the ...

Sanofi SA (NASDAQ:SNY) and Johnson & Johnson (NYSE:JNJ) have discontinued the E.mbrace phase 3 study evaluating a vaccine candidate for extraintestinal pathogenic E. coli. The E.mbrace study is a ...

Nielsen, 28, was diagnosed with MS aged 17 and initially believed that her athletics dreams were over due to her lack of ...

While Sanofi's list price of Aubagio is set at £13,529 ($22,100) per patient a year, NICE was able to recommend it for the NHS after Sanofi made the drug available at a discount under the patient ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Altuvoct (efanesoctocog alfa) to be used to ...

Advisers scored lucrative roles on deals in 2024 including Sanofi’s consumer healthcare sale and the take-private of UK cyber ...

Sanofi is calling for national bodies across the UK to publish a comprehensive clinical guideline in NMSC, which we believe will support clinicians in providing the best possible care and ...

The use of digital twins with industrial, manufacturing and architectural use cases is well known, and in the manifold ...

Where could be the top place to invest this spring? Europe. That's according to the latest edition of the hugely influential ...

Team GB athlete Lina Nielsen is starting treatment for multiple sclerosis – a decade after being diagnosed. She tells The i ...

European stocks suffered their biggest decline in two months, hit by the possibility of a shallower-than-expected monetary ...

The leading Advanced Melanoma Companies such as OncoSec Medical, Immunocore, Sanofi, TILT Biotherapeutics, Novartis ...